Sinopharm Holdings and its controlling shareholder Sinopharm Group agreed to sell 51% of Guorui Pharmaceutical's shares to Sinopharm Hyundai, with a transaction amount of approximately 406.4 billion yuan. After the transaction is completed, Sinopharm Holdings will no longer directly hold shares in Guorui Pharmaceutical.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.